HEADER LIGASE 21-AUG-17 6AQQ TITLE CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS BIOTIN PROTEIN LIGASE IN TITLE 2 COMPLEX WITH INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: BIFUNCTIONAL LIGASE/REPRESSOR BIRA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: BIOTIN--[ACETYL-COA-CARBOXYLASE] LIGASE,BIOTIN--PROTEIN COMPND 5 LIGASE,BIOTIN-[ACETYL-COA CARBOXYLASE] SYNTHETASE; COMPND 6 EC: 6.3.4.15; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STAPHYLOCOCCUS AUREUS; SOURCE 3 ORGANISM_TAXID: 1280; SOURCE 4 GENE: BIRA, BO217_2143, SAMEA2236422_00088, SAMEA2236459_00088, SOURCE 5 SAMEA2384800_00088, SAMEA2384856_00382, SAMEA2445640_00088; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ANTIBIOTIC, INHIBITOR, LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR D.A.CINI,M.C.J.WILCE REVDAT 5 13-MAR-24 6AQQ 1 REMARK REVDAT 4 08-JAN-20 6AQQ 1 REMARK REVDAT 3 21-FEB-18 6AQQ 1 JRNL REVDAT 2 14-FEB-18 6AQQ 1 REMARK REVDAT 1 07-FEB-18 6AQQ 0 JRNL AUTH A.S.PAPARELLA,K.J.LEE,A.J.HAYES,J.FENG,Z.FENG,D.CINI, JRNL AUTH 2 S.DESHMUKH,G.W.BOOKER,M.C.J.WILCE,S.W.POLYAK,A.D.ABELL JRNL TITL HALOGENATION OF BIOTIN PROTEIN LIGASE INHIBITORS IMPROVES JRNL TITL 2 WHOLE CELL ACTIVITY AGAINST STAPHYLOCOCCUS AUREUS. JRNL REF ACS INFECT DIS V. 4 175 2018 JRNL REFN ESSN 2373-8227 JRNL PMID 29131575 JRNL DOI 10.1021/ACSINFECDIS.7B00134 REMARK 2 REMARK 2 RESOLUTION. 2.71 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.13_2998: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.71 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.86 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 3 NUMBER OF REFLECTIONS : 15754 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.219 REMARK 3 R VALUE (WORKING SET) : 0.218 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 788 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 41.8642 - 4.9222 0.91 2509 133 0.2169 0.2538 REMARK 3 2 4.9222 - 3.9078 0.95 2488 131 0.1817 0.1900 REMARK 3 3 3.9078 - 3.4141 0.96 2481 130 0.2034 0.2251 REMARK 3 4 3.4141 - 3.1021 0.98 2489 131 0.2355 0.2629 REMARK 3 5 3.1021 - 2.8798 0.98 2497 132 0.2708 0.2821 REMARK 3 6 2.8798 - 2.7100 0.99 2502 131 0.3300 0.4213 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.430 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.700 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 2650 REMARK 3 ANGLE : 0.872 3573 REMARK 3 CHIRALITY : 0.047 389 REMARK 3 PLANARITY : 0.004 461 REMARK 3 DIHEDRAL : 6.616 1581 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 2 THROUGH 68 ) REMARK 3 ORIGIN FOR THE GROUP (A): 25.0348 -26.1212 45.2811 REMARK 3 T TENSOR REMARK 3 T11: 0.6108 T22: 0.6022 REMARK 3 T33: 0.6492 T12: -0.1525 REMARK 3 T13: 0.1070 T23: -0.1241 REMARK 3 L TENSOR REMARK 3 L11: 1.9800 L22: 3.9976 REMARK 3 L33: 3.5510 L12: 1.8149 REMARK 3 L13: 1.9760 L23: 2.6721 REMARK 3 S TENSOR REMARK 3 S11: 0.1787 S12: 0.1690 S13: -0.3624 REMARK 3 S21: 0.1760 S22: 0.1262 S23: -0.5227 REMARK 3 S31: -0.1118 S32: 0.3456 S33: -0.2842 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 69 THROUGH 323 ) REMARK 3 ORIGIN FOR THE GROUP (A): 17.6678 -43.1477 16.3356 REMARK 3 T TENSOR REMARK 3 T11: 0.5265 T22: 0.4303 REMARK 3 T33: 0.4360 T12: -0.0524 REMARK 3 T13: 0.1126 T23: -0.0455 REMARK 3 L TENSOR REMARK 3 L11: 2.3970 L22: 2.4052 REMARK 3 L33: 3.8050 L12: -0.3913 REMARK 3 L13: -0.6558 L23: 1.1853 REMARK 3 S TENSOR REMARK 3 S11: 0.2299 S12: 0.1373 S13: 0.3044 REMARK 3 S21: -0.1894 S22: 0.1650 S23: -0.3540 REMARK 3 S31: -0.3474 S32: 0.7078 S33: -0.3309 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6AQQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-AUG-17. REMARK 100 THE DEPOSITION ID IS D_1000229651. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-NOV-16 REMARK 200 TEMPERATURE (KELVIN) : 77 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.95370 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15757 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.710 REMARK 200 RESOLUTION RANGE LOW (A) : 41.859 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.0800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 67.33 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.77 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12% PEG 8000, 100 MM TRIS-HCL PH 7.5 REMARK 280 AND 10% GLYCEROL, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 42 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y+1/2,X+1/2,Z+1/2 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/2 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 46.80000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 46.80000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 65.35000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 46.80000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 46.80000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 65.35000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 46.80000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 46.80000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 65.35000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 46.80000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 46.80000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 65.35000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 517 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 TRP A 127 REMARK 465 SER A 128 REMARK 465 SER A 129 REMARK 465 SER A 130 REMARK 465 HIS A 324 REMARK 465 HIS A 325 REMARK 465 HIS A 326 REMARK 465 HIS A 327 REMARK 465 HIS A 328 REMARK 465 HIS A 329 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 222 CG CD OE1 OE2 REMARK 470 LYS A 236 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD2 ASP A 180 O HOH A 501 1.99 REMARK 500 O PHE A 220 NH2 ARG A 225 2.04 REMARK 500 O GLN A 216 N ASN A 219 2.09 REMARK 500 NE2 GLN A 232 O ASN A 237 2.15 REMARK 500 OH TYR A 182 O HOH A 502 2.17 REMARK 500 OH TYR A 19 OD2 ASP A 51 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 55 -26.16 73.57 REMARK 500 LYS A 118 49.21 -143.66 REMARK 500 ASN A 179 18.22 -146.18 REMARK 500 ASP A 184 -130.00 58.61 REMARK 500 LEU A 213 -117.16 -107.32 REMARK 500 THR A 214 76.42 -52.79 REMARK 500 GLN A 216 116.56 -28.89 REMARK 500 LEU A 217 -93.04 4.37 REMARK 500 GLU A 218 -74.53 3.42 REMARK 500 ASN A 219 -116.41 -58.77 REMARK 500 PHE A 220 91.73 6.82 REMARK 500 ASP A 221 111.95 18.93 REMARK 500 GLU A 222 35.27 -72.50 REMARK 500 SER A 223 -119.15 -84.07 REMARK 500 ILE A 224 60.11 -67.27 REMARK 500 ARG A 225 25.34 -64.10 REMARK 500 ARG A 227 19.56 -145.86 REMARK 500 LEU A 233 4.10 -62.92 REMARK 500 ASN A 287 -127.89 65.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 LEU A 217 GLU A 218 144.61 REMARK 500 PHE A 220 ASP A 221 144.26 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue BVY A 401 DBREF1 6AQQ A 1 323 UNP A0A181HT70_STAAU DBREF2 6AQQ A A0A181HT70 1 323 SEQADV 6AQQ HIS A 324 UNP A0A181HT7 EXPRESSION TAG SEQADV 6AQQ HIS A 325 UNP A0A181HT7 EXPRESSION TAG SEQADV 6AQQ HIS A 326 UNP A0A181HT7 EXPRESSION TAG SEQADV 6AQQ HIS A 327 UNP A0A181HT7 EXPRESSION TAG SEQADV 6AQQ HIS A 328 UNP A0A181HT7 EXPRESSION TAG SEQADV 6AQQ HIS A 329 UNP A0A181HT7 EXPRESSION TAG SEQRES 1 A 329 MET SER LYS TYR SER GLN ASP VAL LEU GLN LEU LEU TYR SEQRES 2 A 329 LYS ASN LYS PRO ASN TYR ILE SER GLY GLN SER ILE ALA SEQRES 3 A 329 GLU SER LEU ASN ILE SER ARG THR ALA VAL LYS LYS VAL SEQRES 4 A 329 ILE ASP GLN LEU LYS LEU GLU GLY CYS LYS ILE ASP SER SEQRES 5 A 329 VAL ASN HIS LYS GLY HIS LEU LEU GLN GLN LEU PRO ASP SEQRES 6 A 329 ILE TRP TYR GLN GLY ILE ILE ASP GLN TYR THR LYS SER SEQRES 7 A 329 SER ALA LEU PHE ASP PHE SER GLU VAL TYR ASP SER ILE SEQRES 8 A 329 ASP SER THR GLN LEU ALA ALA LYS LYS SER LEU VAL GLY SEQRES 9 A 329 ASN GLN SER SER PHE PHE ILE LEU SER ASP GLU GLN THR SEQRES 10 A 329 LYS GLY ARG GLY ARG PHE ASN ARG HIS TRP SER SER SER SEQRES 11 A 329 LYS GLY GLN GLY LEU TRP MET SER VAL VAL LEU ARG PRO SEQRES 12 A 329 ASN VAL ALA PHE SER MET ILE SER LYS PHE ASN LEU PHE SEQRES 13 A 329 ILE ALA LEU GLY ILE ARG ASP ALA ILE GLN HIS PHE SER SEQRES 14 A 329 GLN ASP GLU VAL LYS VAL LYS TRP PRO ASN ASP ILE TYR SEQRES 15 A 329 ILE ASP ASN GLY LYS VAL CYS GLY PHE LEU THR GLU MET SEQRES 16 A 329 VAL ALA ASN ASN ASP GLY ILE GLU ALA ILE ILE CYS GLY SEQRES 17 A 329 ILE GLY ILE ASN LEU THR GLN GLN LEU GLU ASN PHE ASP SEQRES 18 A 329 GLU SER ILE ARG HIS ARG ALA THR SER ILE GLN LEU HIS SEQRES 19 A 329 ASP LYS ASN LYS LEU ASP ARG TYR GLN PHE LEU GLU ARG SEQRES 20 A 329 LEU LEU GLN GLU ILE GLU LYS ARG TYR ASN GLN PHE LEU SEQRES 21 A 329 THR LEU PRO PHE SER GLU ILE ARG GLU GLU TYR ILE ALA SEQRES 22 A 329 ALA SER ASN ILE TRP ASN ARG THR LEU LEU PHE THR GLU SEQRES 23 A 329 ASN ASP LYS GLN PHE LYS GLY GLN ALA ILE ASP LEU ASP SEQRES 24 A 329 TYR ASP GLY TYR LEU ILE VAL ARG ASP GLU ALA GLY GLU SEQRES 25 A 329 SER HIS ARG LEU ILE SER ALA ASP ILE ASP PHE HIS HIS SEQRES 26 A 329 HIS HIS HIS HIS HET BVY A 401 27 HETNAM BVY (3AS,4S,6AR)-4-(5-{1-[(3-FLUOROPHENYL)METHYL]-1H-1,2,3- HETNAM 2 BVY TRIAZOL-4-YL}PENTYL)TETRAHYDRO-1H-THIENO[3,4- HETNAM 3 BVY D]IMIDAZOL-2(3H)-ONE FORMUL 2 BVY C19 H24 F N5 O S FORMUL 3 HOH *21(H2 O) HELIX 1 AA1 TYR A 4 ASN A 15 1 12 HELIX 2 AA2 SER A 21 ASN A 30 1 10 HELIX 3 AA3 SER A 32 GLU A 46 1 15 HELIX 4 AA4 TYR A 68 SER A 79 1 12 HELIX 5 AA5 SER A 93 LEU A 102 1 10 HELIX 6 AA6 GLY A 121 ARG A 125 5 5 HELIX 7 AA7 ALA A 146 SER A 148 5 3 HELIX 8 AA8 MET A 149 SER A 169 1 21 HELIX 9 AA9 SER A 230 ASP A 235 5 6 HELIX 10 AB1 ASP A 240 LEU A 262 1 23 HELIX 11 AB2 PRO A 263 ALA A 274 1 12 SHEET 1 AA1 2 LYS A 49 VAL A 53 0 SHEET 2 AA1 2 GLY A 57 GLN A 62 -1 O GLN A 62 N LYS A 49 SHEET 1 AA2 7 PHE A 84 ILE A 91 0 SHEET 2 AA2 7 PHE A 109 GLN A 116 1 O LEU A 112 N GLU A 86 SHEET 3 AA2 7 GLY A 134 LEU A 141 -1 O VAL A 140 N PHE A 109 SHEET 4 AA2 7 GLY A 201 ASN A 212 -1 O ILE A 209 N MET A 137 SHEET 5 AA2 7 GLY A 186 ASN A 198 -1 N VAL A 196 O GLU A 203 SHEET 6 AA2 7 ASP A 180 ILE A 183 -1 N ILE A 183 O GLY A 186 SHEET 7 AA2 7 VAL A 173 LYS A 176 -1 N LYS A 174 O TYR A 182 SHEET 1 AA3 5 SER A 313 LEU A 316 0 SHEET 2 AA3 5 LEU A 304 ASP A 308 -1 N LEU A 304 O LEU A 316 SHEET 3 AA3 5 LYS A 289 LEU A 298 -1 N ILE A 296 O ILE A 305 SHEET 4 AA3 5 LEU A 282 GLU A 286 -1 N LEU A 282 O GLY A 293 SHEET 5 AA3 5 ASP A 320 ASP A 322 -1 O ASP A 322 N LEU A 283 CISPEP 1 LYS A 16 PRO A 17 0 6.75 CISPEP 2 TRP A 177 PRO A 178 0 -0.75 SITE 1 AC1 9 SER A 93 THR A 94 GLN A 95 GLN A 116 SITE 2 AC1 9 GLY A 119 ARG A 120 ARG A 125 LYS A 187 SITE 3 AC1 9 GLY A 190 CRYST1 93.600 93.600 130.700 90.00 90.00 90.00 P 42 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010684 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010684 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007651 0.00000